Comparable stake leader
JPMORGAN CHASE & CO
SEC ownership of Natera, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001604821.
Disclosed value leader
JPMORGAN CHASE & CO
Comparable rows
4/50
Latest evidence
27 Oct 2026
- Public ticker
- NTRA on Nasdaq
- Parsed ownership sources
-
13F, 13D/G, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
JPMORGAN CHASE & CO
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
4 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
JPMORGAN CHASE & CO
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
27 Oct 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001604821
- Issuer location
- Austin, TX
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Natera, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
JPMORGAN CHASE & CO
Disclosed value leader
JPMORGAN CHASE & CO
Comparable rows
4/50
Latest evidence
27 Oct 2026
13F
13D/G
3/4/5
Lead comparable stake: 9.1%
46 rows are not safely comparable across share classes.
13D/G row: JPMORGAN CHASE & CO
Showing 1-8 of 50 holder rows.
Quick read
JPMORGAN CHASE & CO leads the comparable SEC ownership view at 9.1%.
4 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens JPMORGAN CHASE & CO's linked filing trail.
Comparable ownership
Top 4
JPMORGAN CHASE & CO
9.1%
PRICE T ROWE ASSOCIATES INC /MD/
6.3%
BlackRock, Inc.
5.6%
VANGUARD CAPITAL MANAGEMENT LLC
5.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JPMORGAN CHASE & CO |
13F
13D/G
Company
|
9.1%
Reported 13D/G
· 31 Dec 2025
|
$3,505,094,525
12,865,346 shares
|
— | 30 Jun 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13D/G
13F
T. Rowe Price Associates, Inc. · Company
|
6.3%
Reported 13D/G
· 30 Jun 2026
|
$2,475,498,562
9,021,825 shares
|
-$507,862,140 | 30 Jun 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
5.6%
Reported 13D/G
· 31 Mar 2025
|
$2,962,770,331
10,914,608 shares
|
— | 30 Jun 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
13D/G
Company · Vanguard Capital Management
|
5.1%
Reported 13D/G
· 31 Mar 2026
|
$1,690,649,234
6,228,216 shares
|
— | 30 Jun 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$1,569,697,628
5,782,640 shares
|
— | 30 Jun 2026 |
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$1,479,781,281
5,451,396 shares
|
— | 30 Jun 2026 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
—
denominator unverified
|
$1,096,858,330
4,040,738 shares
|
— | 30 Jun 2026 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$992,317,506
3,655,618 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$401,747,321.
Buys
$0
Insiders: 0
Sells
$401,747,321
Insiders: 12
Net
-$401,747,321
Shares: -1,648,832
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 1,648,832
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 305,984 | $0 | $108,075,380 | -$108,075,380 |
| 3-6 | 0 | 356,576 | $0 | $81,201,173 | -$81,201,173 |
| 6-9 | 0 | 373,053 | $0 | $76,226,726 | -$76,226,726 |
| 9-12 | 0 | 613,219 | $0 | $136,244,043 | -$136,244,043 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-19 of 19 reporting-owner rows connected to Natera, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
19
Largest Forms 3/4/5 holder
Matthew Rabinowitz
Net 12M change
-$394.91M
Full value: -$394,909,636 · USD · 12-month changeLatest report
27 Oct 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Matthew Rabinowitz | EXECUTIVE CHAIRMAN, Director | $859,776,456 | -$142,277,367 | -14% | Filing P/S | 27 Oct 2026 |
| James Healy | Director | $225,766,720 | Mixed | 25 Apr 2025 | ||
| Roelof Botha | Director | $216,145,792 | -$34,893,028 | -14% | Mixed | 26 Jun 2026 |
| Jonathan Sheena | Director, CO-FOUNDER | $99,627,950 | -$30,820,392 | -24% | Mixed | 27 Oct 2026 |
| John Fesko | President, Chief Bus. Officer | $83,382,802 | -$8,954,049 | -9.7% | Filing P/S | 27 Oct 2026 |
| Daniel Rabinowitz | Sec. And Chief Legal Officer | $71,719,408 | -$23,139,472 | -24% | Mixed | 27 Oct 2026 |
| Solomon Moshkevich | President, Clinicaldiagnostics | $44,655,746 | -$23,162,354 | -34% | Filing P/S | 27 Oct 2026 |
| Steven Leonard Chapman | CEO AND PRESIDENT, Director | $38,895,887 | -$89,293,845 | -70% | Mixed | 27 Oct 2026 |
| Michael Burkes Brophy | Chief Financial Officer | $21,171,211 | -$20,237,518 | -49% | Mixed | 27 Oct 2026 |
| Robert Alan Schueren | Chief Operating Officer | $9,082,035 | Mixed | 27 Jan 2023 | ||
| Roy D. Baynes | Director | $4,031,398 | -$2,809,689 | -41% | Mixed | 26 Jun 2026 |
| Gail Boxer Marcus | Director | $1,778,045 | -$2,413,571 | -58% | Mixed | 26 Jun 2026 |
| Monica Bertagnolli | Director | $1,403,929 | Mixed | 26 Jun 2026 | ||
| Rowan E. Chapman | Director | $1,281,485 | -$1,764,374 | -58% | Filing P/S | 15 Jul 2026 |
| Herm Rosenman | Director | $1,185,340 | -$15,143,977 | -93% | Mixed | 26 Jun 2026 |
| Brinkley Ruth Williams | Director | $1,094,945 | Mixed | 24 Apr 2026 | ||
| Todd C. Cozzens | Director | $1,038,936 | Mixed | 25 May 2022 | ||
| Eric H. Rubin | Director | $440,777 | Mixed | 26 Jun 2026 | ||
| Thomas J. Lynch Jr. | Director | $380,980 | Mixed | 26 Jun 2026 |
Recent insider transactions for Natera, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Jonathan Sheena | NTRA | Common Stock | Sale | -0.09% | -$79,726 | $426.34 | -187 | 217,686 | 28 Oct 2026 | Direct |
| Daniel Rabinowitz | NTRA | Common Stock | Sale | -0.57% | -$412,698 | $426.34 | -968 | 168,221 | 28 Oct 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Sale | -1.1% | -$495,408 | $426.34 | -1,162 | 104,742 | 28 Oct 2026 | Direct |
| John Fesko | NTRA | Common Stock | Sale | -0.46% | -$382,854 | $426.34 | -898 | 195,578 | 28 Oct 2026 | Direct |
| Steven Leonard Chapman | NTRA | Common Stock | Sale | -3.62% | -$1,462,348 | $426.34 | -3,430 | 91,232 | 28 Oct 2026 | Direct |
| Michael Burkes Brophy | NTRA | Common Stock | Sale | -2.36% | -$510,756 | $426.34 | -1,198 | 49,658 | 28 Oct 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -0.13% | -$118,146 | $406.00 | -291 | 217,873 | 27 Oct 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -0.08% | -$697,508 | $406.00 | -1,718 | 2,117,676 | 27 Oct 2026 | Direct |
| Daniel Rabinowitz | NTRA | Common Stock | Sale | -0.52% | -$358,904 | $406.00 | -884 | 169,189 | 27 Oct 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Sale | -0.94% | -$410,060 | $406.00 | -1,010 | 105,904 | 27 Oct 2026 | Direct |
| John Fesko | NTRA | Common Stock | Sale | -0.4% | -$317,086 | $406.00 | -781 | 196,476 | 27 Oct 2026 | Direct |
| Steven Leonard Chapman | NTRA | Common Stock | Sale | -2.34% | -$919,184 | $406.00 | -2,264 | 94,662 | 27 Oct 2026 | Direct |
| Michael Burkes Brophy | NTRA | Common Stock | Sale | -1.51% | -$317,086 | $406.00 | -781 | 50,856 | 27 Oct 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -1.42% | -$1,293,246 | $410.55 | -3,150 | 218,164 | 21 Oct 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -8.33% | -$301,871 | $402.49 | -750 | 8,250 | 16 Oct 2026 | By Caraluna 2 Trust |
| Jonathan Sheena | NTRA | Common Stock | Sale | -3% | -$103,621 | $406.36 | -255 | 8,250 | 16 Oct 2026 | by Caraluna 1 Trust |
| Jonathan Sheena | NTRA | Common Stock | Sale | -5.5% | -$198,219 | $400.44 | -495 | 8,505 | 16 Oct 2026 | By Caraluna 1 Trust |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -2.3% | -$20,132,028 | $402.64 | -50,000 | 2,119,394 | 15 Oct 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Options Exercise | 2.36% | 50,000 | 2,169,394 | 15 Oct 2026 | Direct | ||
| Matthew Rabinowitz | NTRA | Stock Option (right to buy) | Options Exercise | -100% | -50,000 | 0 | 15 Oct 2026 | Direct | ||
| Matthew Rabinowitz | NTRA | Common Stock | Gift | -0.28% | -6,000 | 2,119,394 | 07 Oct 2026 | Direct | ||
| Steven Leonard Chapman | NTRA | Common Stock | Sale | -1.3% | -$526,144 | $413.31 | -1,273 | 96,926 | 01 Oct 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Sale | -2.73% | -$1,242,645 | $414.22 | -3,000 | 106,914 | 01 Oct 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -50.1% | -$3,504,367 | $387.99 | -9,032 | 9,000 | 23 Sep 2026 | By Caraluna 2 Trust |
| Jonathan Sheena | NTRA | Common Stock | Sale | -50.1% | -$3,504,606 | $388.02 | -9,032 | 9,000 | 23 Sep 2026 | By Caraluna 1 Trust |
| Solomon Moshkevich | NTRA | Common Stock | Gift | -0.85% | -945 | 109,914 | 16 Sep 2026 | Direct | ||
| Jonathan Sheena | NTRA | Common Stock | Sale | -1.4% | -$1,115,714 | $354.19 | -3,150 | 221,314 | 16 Sep 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -2.6% | -$2,100,431 | $350.07 | -6,000 | 224,464 | 15 Sep 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -100% | -$700,014 | $350.01 | -2,000 | 0 | 15 Sep 2026 | By spouse |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -2.3% | -$17,359,280 | $347.19 | -50,000 | 2,125,394 | 15 Sep 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -2.25% | -$16,737,977 | $334.76 | -50,000 | 2,175,394 | 14 Sep 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -2.2% | -$16,398,267 | $327.97 | -50,000 | 2,225,394 | 11 Sep 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Sale | -12% | -$4,955,713 | $326.89 | -15,160 | 110,859 | 02 Sep 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Sale | -2.33% | -$962,194 | $320.73 | -3,000 | 126,019 | 01 Sep 2026 | Direct |
| Steven Leonard Chapman | NTRA | Common Stock | Sale | -1.7% | -$545,041 | $320.99 | -1,698 | 98,199 | 01 Sep 2026 | Direct |
| John Fesko | NTRA | Common Stock | Sale | -3.2% | -$2,095,411 | $321.53 | -6,517 | 197,257 | 10 Aug 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -2.54% | -$1,951,942 | $325.32 | -6,000 | 230,464 | 10 Aug 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -50% | -$641,800 | $320.90 | -2,000 | 2,000 | 07 Aug 2026 | By spouse |
| Jonathan Sheena | NTRA | Common Stock | Sale | -3.73% | -$2,888,325 | $315.66 | -9,150 | 236,464 | 07 Aug 2026 | Direct |
| John Fesko | NTRA | Common Stock | Award | 10.9% | 20,000 | 203,774 | 06 Aug 2026 | Direct | ||
| Michael Burkes Brophy | NTRA | Common Stock | Sale | -0.92% | -$131,077 | $274.22 | -478 | 51,637 | 04 Aug 2026 | Direct |
| Michael Burkes Brophy | NTRA | Common Stock | Sale | -0.6% | -$84,953 | $267.99 | -317 | 52,115 | 03 Aug 2026 | Direct |
| Steven Leonard Chapman | NTRA | Common Stock | Sale | -2.99% | -$819,431 | $266.40 | -3,076 | 99,897 | 03 Aug 2026 | Direct |
| John Fesko | NTRA | Common Stock | Sale | -0.16% | -$79,057 | $267.99 | -295 | 183,774 | 03 Aug 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Sale | -2.57% | -$905,627 | $265.58 | -3,410 | 129,019 | 03 Aug 2026 | Direct |
| Daniel Rabinowitz | NTRA | Common Stock | Sale | -0.2% | -$89,508 | $267.99 | -334 | 170,073 | 03 Aug 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -0.03% | -$195,900 | $267.99 | -731 | 2,275,394 | 03 Aug 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -0.04% | -$29,211 | $267.99 | -109 | 245,614 | 03 Aug 2026 | Direct |
| Michael Burkes Brophy | NTRA | Common Stock | Sale | -3.43% | -$464,595 | $249.38 | -1,863 | 52,432 | 29 Jul 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -0.08% | -$48,527 | $254.07 | -191 | 245,723 | 28 Jul 2026 | Direct |
* marks a reported price that did not pass the local price check.